Geneos Wealth Management’s Oaktree Specialty Lending OCSL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.9K Hold
1,000
﹤0.01% 1956
2026
Q1
$11.3K Sell
1,000
-5,017
-83% -$60K ﹤0.01% 1958
2025
Q4
$76.7K Buy
6,017
+76
+1% +$1.01K ﹤0.01% 1243
2025
Q3
$77.5K Buy
5,941
+72
+1% +$992 ﹤0.01% 1212
2025
Q2
$80.2K Sell
5,869
-258
-4% -$3.64K ﹤0.01% 1339
2025
Q1
$94.1K Buy
6,127
+66
+1% +$1.03K ﹤0.01% 1190
2024
Q4
$92.6K Buy
+6,061
New +$97.1K ﹤0.01% 1096
2022
Q3
Sell
-842
Closed -$16K 2410
2022
Q2
$16K Buy
842
+3
+0.4% +$63 ﹤0.01% 1786
2022
Q1
$18K Sell
839
-364
-30% -$8.15K ﹤0.01% 1862
2021
Q4
$26K Buy
1,203
+3
+0.3% +$66 ﹤0.01% 1749
2021
Q3
$25K Buy
1,200
+2
+0.2% +$42 ﹤0.01% 1805
2021
Q2
$24K Buy
1,198
+2
+0.2% +$40 ﹤0.01% 1820
2021
Q1
$23K Hold
1,196
﹤0.01% 2008
2020
Q4
$22K Buy
1,196
+7
+0.6% +$109 ﹤0.01% 1852
2020
Q3
$16K Buy
1,189
+368
+45% +$5.26K ﹤0.01% 1759
2020
Q2
$10K Buy
821
+3
+0.4% +$37 ﹤0.01% 1918
2020
Q1
$8K Sell
818
-421
-34% -$6.14K ﹤0.01% 1899
2019
Q4
$20K Buy
1,239
+1
+0.1% +$16 ﹤0.01% 1691
2019
Q3
$19K Hold
1,238
﹤0.01% 1636
2019
Q2
$20K Buy
1,238
+2
+0.2% +$32 ﹤0.01% 1631
2019
Q1
$19K Buy
1,236
+2
+0.2% +$30 ﹤0.01% 1602
2018
Q4
$15K Buy
1,234
+2
+0.2% +$27 ﹤0.01% 1634
2018
Q3
$18K Buy
1,232
+1
+0.1% +$15 ﹤0.01% 1625
2018
Q2
$17K Buy
1,231
+4
+0.3% +$56 ﹤0.01% 1525
2018
Q1
$15K Sell
1,227
-517
-30% -$7.16K ﹤0.01% 1509
2017
Q4
$25K Buy
+1,744
New +$27.9K ﹤0.01% 1298

Other funds holding OCSL

Geneos Wealth Management's OCSL Position: Q2 2026 in Review

Geneos Wealth Management held its Oaktree Specialty Lending (OCSL) position steady in Q2 2026 at 1,000 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1956.

Geneos Wealth Management first reported a position in OCSL in Q4 2017 and has held it in 26 quarters since. The position peaked at $94.1K in Q1 2025. 165 funds tracked by Wall St. Rank hold OCSL as of Q2 2026.

  • Geneos Wealth Management held 1,000 shares of Oaktree Specialty Lending worth $11.9K as of Q2 2026.
  • Geneos Wealth Management left its Oaktree Specialty Lending share count unchanged in Q2 2026.
  • Oaktree Specialty Lending made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1956 holding.
  • Geneos Wealth Management first reported a position in Oaktree Specialty Lending in Q4 2017 and has held it in 26 quarters since.
  • Geneos Wealth Management's Oaktree Specialty Lending position peaked at $94.1K in Q1 2025.
  • 165 funds tracked by Wall St. Rank held Oaktree Specialty Lending as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.